Showing results (81-90 of 290) with videos related to

Sort By:
Pageof 29
Scandinavian Journal of Gastroenterology|September 6, 2000
Type I and III collagens in human colon cancer and diverticulosisM K Bode, T J Karttunen, J Mäkelä, et al.
Cancer|December 1, 1990
Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinomaC Tomás, J Penttinen, J Risteli, et al.
British Journal of Haematology|July 1, 1986
Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosisM Apaja-Sarkkinen, H Autio-Harmainen, M Alavaikko, et al.
British Journal of Cancer|May 1, 1996
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinomaC Blomqvist, L Risteli, J Risteli, et al.
Spine|April 15, 1997
Low synthesis rate of type I procollagen is normalized during active back rehabilitationM Hupli, H Hurri, S Luoto, et al.
The British Journal of Dermatology|September 1, 1988
Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosisJ Risteli, H Søgaard, A Oikarinen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer GroupT Kylmälä, T Tammela, L Risteli, et al.
Archives of Dermatological Research|January 1, 1993
Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatmentP Autio, J Risteli, U Kiistala, et al.
International Journal of Andrology|October 1, 1985
Laminin and type IV collagen in the human testisP P Pöllänen, M Kallajoki, L Risteli, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomasT A Wiklund, C P Blomqvist, L Risteli, et al.
Pageof 29